Side-by-side comparison of AI visibility scores, market position, and capabilities
Colgate-Palmolive subsidiary (NYSE: CL); $4.48B revenue 2024 (+4.4% YoY); #1 vet-recommended therapeutic pet food; Science Diet and Prescription Diet lines sold in 100+ countries
Hill's Pet Nutrition is a premium pet food company founded in 1948 by veterinarian Mark Morris Sr., who developed a therapeutic kidney diet for a guide dog — an origin story that established the company's foundational identity as a veterinarian-recommended, science-based nutrition brand. Acquired by Colgate-Palmolive in 1976, Hill's has operated as a wholly owned subsidiary ever since, with its R&D, manufacturing, and go-to-market strategy aligned tightly with the veterinary community as both a clinical partner and primary distribution channel.\n\nHill's product portfolio is organized around two flagship lines: Science Diet, a life-stage and lifestyle nutrition range for healthy pets sold through veterinarians and pet specialty retailers; and Prescription Diet, a therapeutic nutrition line for pets with specific health conditions including kidney disease, urinary issues, obesity, diabetes, and food sensitivities that requires veterinary recommendation. The Prescription Diet line is Hill's most defensible product — its clinical validation, veterinary relationships, and regulatory positioning create high barriers to entry that commodity pet food brands cannot easily overcome.\n\nHill's Pet Nutrition is the veterinarian-recommended #1 pet food brand in the US and a major revenue contributor to Colgate-Palmolive's consumer products portfolio. As pet humanization drives premiumization in the $140B+ global pet care market, Hill's Prescription Diet line benefits from both the growing willingness to spend on pet health and the shift toward preventive and therapeutic nutrition supported by veterinary guidance. The brand's clinical heritage, vet channel dominance, and Colgate-Palmolive's global distribution infrastructure give it a durable competitive position in premium and prescription pet nutrition.
Q3 2025 $1.63B revenue (+25.1% YoY); 156K locations powered globally; $2.0B+ ARR (+30% YoY); $159.1B GPV FY2024 (+26% YoY); 97.36% customers from US; restaurant POS leader
Toast was founded in 2011 in Boston with the mission of building an all-in-one technology platform purpose-built for the restaurant industry. Unlike generic point-of-sale vendors that adapted retail software for food service, Toast designed its hardware, software, and payments stack from the ground up around restaurant workflows — table management, kitchen display systems, online ordering, payroll, and inventory unified in a single cloud platform.\n\nToast's product suite covers the full restaurant operating stack: POS terminals and handheld order devices, kitchen display screens, Toast Go handhelds for tableside payments, online ordering and delivery integrations, catering management, payroll and scheduling, and xtraCHEF for back-of-house food cost analytics. The platform serves independent restaurants, multi-location chains, quick-service concepts, and enterprise groups. Its open API allows integrations with hundreds of third-party tools, and the Toast for Enterprise tier serves national brands with centralized menu and reporting management.\n\nAs of Q3 2025, Toast reported $1.63 billion in quarterly revenue, up 25.1% year-over-year, with annualized recurring revenue exceeding $2 billion and gross payment volume of $159.1 billion for fiscal 2024. The company serves more than 156,000 restaurant locations globally and trades on the NYSE under the ticker TOST. Toast's vertical focus and deep restaurant-specific functionality give it a durable competitive moat against horizontal POS vendors.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.